Skip to main content
. 2017 Apr 13;22(6):700–708. doi: 10.1634/theoncologist.2016-0345

Table 2. Correlative analysis of clinical trial endpoints supporting approval of investigational agents for NSCLC.

image

Abbreviations: BSC, best supportive care; NSCLC, non‐small cell lung cancer; ORR, objective response rate; OS, overall survival; PFS, progression‐free survival.